Prostate cancer Board decisions

The Board has determined that the veteran's service-connected schizophrenia caused his death, warranting DIC benefits and service connection for cause of death.

The veteran's prostate cancer is presumed to have been incurred in service due to herbicide exposure, and the Board has granted service connection for this condition.

The Board denied the veteran's claims for service connection of a chronic acquired skin disorder, a rating in excess of 20 percent for prostate cancer residuals, and an initial compensable rating for erectile dysfunction. The appeals were based on secondary service connection due to exposure to Agent Orange.

The Board denied the claim for service connection for the cause of the veteran's death, finding that prostate cancer was not incurred in or aggravated by active service and did not substantially contribute to his death.

The veteran's claim for reimbursement of prescription drugs purchased on March 13, 2001 was denied as he is not eligible to have non-VA prescriptions filled at a VA pharmacy and the criteria for reimbursement are not met.

The Board found that the veteran's current disabilities, including anemia and colostomy, were not due to VA's radiation therapy for prostate cancer. The evidence showed these complications are common side effects of radiation treatment for prostate cancer.

The Board found that the veteran's death was not caused by a service-connected disability, and thus denied the claim for service connection for the cause of the veteran's death.

The Board denied service connection for cervical stenosis, degenerative joint disease of the thoracic spine, hypertension, and prostate cancer with prostectomy as there was no evidence linking these conditions to service.

The Board has determined that the veteran's current disability rating for prostate cancer residuals is not sufficient to warrant restoration of a 100 percent evaluation, as there is no evidence of recurrence or metastasis and the maximum schedular rating has been granted.

The Board denied the veteran's claims for service connection for a back disorder, including arthritis; skin cancer; and prostate cancer, all of which were secondary to exposure to ionizing radiation. The Board found that there was no evidence linking these conditions to his period of active service.

The Board found that the veteran's prostate cancer, which caused his death, was not incurred in or aggravated by service and denied the claim for service connection. The cause of death was attributed to metastatic prostate cancer.

The Board denied the veteran's claims for service connection for prostate cancer and TDIU, finding that there was no evidence of radiation exposure during service.

The Board denied the veteran's claim for restoration of a 100% evaluation for service-connected prostate cancer and residuals thereof, finding that there were no current symptomatic residuals.

The Board denied an increased rating for the service-connected residuals of prostate cancer, finding that the current 60 percent evaluation is the maximum under Diagnostic Code 7528 and there is no evidence to support a higher evaluation.

The Board found no evidence to support a connection between the veteran's prostate cancer and his service, including exposure to ionizing radiation. The claim was denied.

The Board has denied the veteran's claim for service connection for residuals of prostate cancer, claimed as a residual of exposure to ionizing radiation. The appeal is based on direct evidence and no presumption or secondary theory was applied.

The Board denied the veteran's claim of service connection for prostate cancer, finding that it was not incurred in or aggravated by service and could not be presumed due to exposure to ionizing radiation.

The Board denied service connection for poor leg circulation, varicose veins, prostate cancer, and sleep apnea. The claim of service connection for PTSD was not addressed as it is not a direct service connection issue.

The veteran's claim for compensation under 38 U.S.C.A. § 1151 was denied because there is no clinical or other competent evidence showing additional disability as a result of VA's failure to diagnose and treat prostate cancer in October 1990.

The Board has reopened the veteran's claims for service connection for myoclonus and prostate cancer secondary to exposure to ionizing radiation, but has denied both claims as there is no evidence that these conditions were incurred during or aggravated by military service.